These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18819344)

  • 1. [The role of cytokines in restenosing coronary stents and the efficiency of its secondary prophylaxis with statins].
    Tepliakov AT; Rybal'chenko EV
    Klin Med (Mosk); 2008; 86(8):32-9. PubMed ID: 18819344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cytokines in improvement of coronary restenosis risk stratification after endovascular stenting in patients with ischemic heart disease].
    Tepliakov AT; Rybal'chenko EV; Suslova TE; Mamchur SE
    Ter Arkh; 2008; 80(9):45-52. PubMed ID: 19555037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of coronary endovascular revascularisation with sirolimus-eluting stents in patients with ischemic heart disease comorbid with type-2 diabetes mellitus: data from 18-month prospective study].
    Tepliakov AT; Torim IuIu; Kuznetsova AV; Rybal'chenko EV; Krylov AL; Karpov RS
    Ter Arkh; 2009; 81(5):54-60. PubMed ID: 19537588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on restenosis after coronary stent implantation.
    Kamishirado H; Inoue T; Sakuma M; Tsuda T; Hayashi T; Takayanagi K; Node K
    Angiology; 2007; 58(1):55-60. PubMed ID: 17351158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of intracoronary stenting made in different periods after diagnostic coronary angiography].
    Savchenko AP; Rudenko BA; Matchin IuG
    Vestn Rentgenol Radiol; 1999; (3):4-7. PubMed ID: 12717875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
    van Werkum JW; Heestermans AA; de Korte FI; Kelder JC; Suttorp MJ; Rensing BJ; Zwart B; Brueren BR; Koolen JJ; Dambrink JH; van't Hof AW; Verheugt FW; ten Berg JM
    Circulation; 2009 Feb; 119(6):828-34. PubMed ID: 19188507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
    Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
    Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of point stenting of extended coronary stenoses in patients with ischemic heart disease].
    Puretskiĭ MV; Abugov SA; Saakian IuM
    Vestn Rentgenol Radiol; 2003; (6):17-24. PubMed ID: 14674350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
    Lasala JM; Cox DA; Morris DL; Breall JA; Mahoney PD; Horwitz PA; Shaw D; Hood KL; Mandinov L; Dawkins KD
    Am J Cardiol; 2009 Jun; 103(12):1663-71. PubMed ID: 19539073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of cholesterol-lowering therapy on the results of coronary arterial stenting in patients with chronic forms of coronary heart disease].
    Arablinskiĭ AV; Zakharova OV; Ioseliani DG
    Klin Med (Mosk); 2006; 84(7):13-6. PubMed ID: 16924793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon-expandable covered stent therapy of complex endovascular pathology.
    Giles H; Lesar C; Erdoes L; Sprouse R; Myers S
    Ann Vasc Surg; 2008 Nov; 22(6):762-8. PubMed ID: 18922676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
    Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Fujita H; Inoue N; Takahashi H; Ono T
    Nephrol Dial Transplant; 2006 Jun; 21(6):1640-7. PubMed ID: 16431887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.